Cargando…
Myelomatous ascites and pleural effusion in relapsed multiple myeloma
Extramedullary multiple myeloma is seen in advanced and aggressive disease and occurs due to plasma cell infiltration of sites other than the bone marrow. Myelomatous ascites or pleural effusion is seen in less than 1% of cases and can be differentiated from infectious etiologies based on fluid cyto...
Autores principales: | Baksh, Mizba, Li, Ke, Jiang, Liuyan, Alegria, Victoria, Sher, Taimur, Roy, Vivek, Chanan‐Khan, Asher, Ailawadhi, Sikander, Parrondo, Ricardo D., Alhaj Moustafa, Muhamad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810939/ https://www.ncbi.nlm.nih.gov/pubmed/35140947 http://dx.doi.org/10.1002/ccr3.5329 |
Ejemplares similares
-
Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature
por: Baksh, Mizba, et al.
Publicado: (2021) -
Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review
por: Parrondo, Ricardo D., et al.
Publicado: (2020) -
RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis
por: Parrondo, Ricardo D., et al.
Publicado: (2022) -
Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting
por: Jayakrishnan, Thejus, et al.
Publicado: (2021) -
Myelomatous pleural effusion
por: Escribano Serrat, Silvia, et al.
Publicado: (2022)